Clinical and epidemiological profile of cerebral venous thrombosis

Article Figures & Data

Download figure
Open in new tab
Download powerpoint
Figure 1
Clinical presentation of patients with Cerebral Venous Thrombosis, Aseer Region-Southern of Saudi Arabia.

Table 1

Personal data of patients with Cerebral Venous Thrombosis, Aseer Region-Southern of Saudi Arabia.

Table 2

Pattern of CVT among affected patients, Aseer Region-Southern of Saudi Arabia.

Pattern of CVT	No	(%)
The duration of the symptoms before presentation (days)
1-2	50	(42)
3-6	38	(31.9)
7+	31	(26.1)
Diagnostic imaging
CTV	63	(52.9)
MRV	56	(47.1)
Imaging done
CT	24	(20.2)
MRI	26	(21.8)
Both	69	(58.0)
Time to do CT (hours)
1-2	21	(22.6)
3-5	36	(38.7)
6-10	16	(17.2)
>10	20	(21.5)
Initial image findings
Normal	27	(29.0)
Hemorrhage ICH	39	(41.9)
Edema or infarct	27	(29.0)
Time to do MRI
<6 hours	21	(22.1)
6-12	24	(25.3)
13-24	23	(24.2)
After 24 hours	27	(28.4)
Average time of diagnosis (days)
1-2	101	(84.9)
3-7	18	(15.1)
Location
Superior Sagittal Sinus	26	(21.8)
Transverse Sinus	21	(17.6)
Sigmoid sinus	12	(10.1)
Superior Sagittal + transverse	16	(13.4)
Transverse + sigmoid	32	(26.9)
Multiple sinuses	12	(10.1)
Right	50	(42.0)
Left	69	(58.0)

Table 3

Risk factors of CVT among affected patients, Aseer Region-Southern of Saudi Arabia.

Risk factors	No	(%)
Family history of DVT/ stroke
No	85	(71.4)
Yes	34	(28.6)
History of hypercoagulopathy state
Yes	43	(44.3)
No	54	(55.7)
Co-morbidity
No	80	(67.2)
DM	14	(11.8)
HTN	9	(7.6)
Others	16	(13.4)
Past history of
CVT	6	(5.0)
PE	8	(6.7)
DVT	10	(8.4)
Other risk factors
OCP	37	(31.1)
Pregnancy	2	(1.7)
Surgery	8	(6.7)
Post-partum	13	(10.9)

Table 4

Admission data of patients with Cerebral Venous Thrombosis, Aseer Region-Southern of Saudi Arabia.

Table 5

Predictors of recanalization among patientswith Cerebral Venous Thrombosis, Aseer Region-Southern of Saudi Arabia.

Predictor	Finding on CT follow up				P-value
	Still thrombus		Recanalization
	n	(%)	n	(%)
Gender
Male	1	(5.9)	16	(94.1)	.881
Female	4	(5.0)	76	(95.0)	.881
Age in years
< 30 years	0	(0.0)	32	(100)	.272
30-39	3	(7.9)	35	(92.1)
40+	2	(7.4)	25	(92.6)
Area
High altitude	3	(4.9)	58	(95.1)	.891
Sea level	2	(5.6)	34	(94.4)	.891
The duration of the symptoms before presentation (days)
1-2	0	(0.0)	44	(100)	.048^*
3-6	3	(11.1)	24	(88.9)
7+	2	(7.7)	24	(92.3)
Location
Superior Sagittal Sinus	2	(9.5)	19	(90.5)	.139
Transverse Sinus	0	(0.0)	17	(100)
Sigmoid sinus	2	(18.2)	9	(81.8)
Superior Sagittal + Transverse	0	(0.0)	14	(100)
Transverse + Sigmoid	0	(0.0)	25	(100)
Superior Sagittal + Transverse + Sigmoid	1	(11.1)	8	(88.9)
Site
Right	2	(4.9)	39	(95.1)	.916
Left	3	(5.4)	53	(94.6)	.916
Initial management
IV heparin	5	(7.2)	64	(92.8)	.144
SC heparin	0	(0.0)	28	(100)	.144
Discharge medication
Warfarin	5	(5.3)	89	(94.7)	.682
NOAC	0	(0.0)	3	(100.0)	.682
Average time of diagnosis (days)
1-2	5	(6.0)	78	(94.0)	.346
3-7	0	(0.0)	14	(100)	.346
Still on medication
Yes	4	(5.6)	68	(94.4)	.762
No	1	(4.0)	24	(96.0)	.762
Complications
Yes	4	(13.8)	25	(86.2)	.012^*
No	1	(1.5)	67	(98.5)	.012^*